Physician profile
Kim Smith
NPI 1194723130
$530.92
in general payments reported to CMS, 2019-2025
8 companies · $211 in 2025
The $211 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $13.23 · 2022: $114 · 2023: $22.25 · 2024: $170 · 2025: $211.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $404.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $403.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $182.62 | 2025 | Ozempic, Rybelsus |
| Phathom Pharmaceuticals, INC. | $119.04 | 2024 | Voquezna |
| Abiomed | $101.97 | 2022 | |
| Daiichi Sankyo INC. | $51.04 | 2023-2025 | Injectafer |
| Xeris Pharmaceuticals, INC. | $32.35 | 2024 | Gvoke Hypopen |
| Astrazeneca Pharmaceuticals Lp | $18.67 | 2024 | Farxiga |
| Genentech USA, INC. | $13.23 | 2021 | |
| Lilly USA, LLC | $12.00 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kim Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.